Association of visceral obesity indicators with prostate cancer: a cross-sectional study from Xinjiang
- Zhiruo Cai 1, Xue Guan 1, Yunyun Xiao 1, Hengqing An 2, Ning Tao 1
- Zhiruo Cai 1, Xue Guan 1, Yunyun Xiao 1
- 1College of Public Health, Xinjiang Medical University, Urumqi, China.
- 2Department of Urology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
- 0College of Public Health, Xinjiang Medical University, Urumqi, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Visceral obesity indicators like VAI and CMI are linked to increased prostate cancer risk. These metrics show promise as potential biomarkers for assessing prostate cancer risk.
Area Of Science
- Urology
- Oncology
- Metabolic Syndrome
Background
- Prostate cancer (PCa) risk is linked to obesity, particularly visceral obesity.
- Existing visceral obesity indices (VAI, CMI, LAP) have underexplored associations with PCa.
- This study examines the relationship between VAI, CMI, LAP, and PCa risk.
Purpose Of The Study
- To investigate the association between visceral adiposity index (VAI), cardiometabolic index (CMI), and lipid accumulation product (LAP) and prostate cancer (PCa) risk.
- To evaluate the predictive efficacy of these obesity indicators for PCa.
- To assess the robustness and clinical utility of VAI and CMI as potential PCa biomarkers.
Main Methods
- Cross-sectional study of 730 participants (102 PCa patients, 102 controls) using propensity score matching.
- Calculation of VAI, CMI, and LAP from anthropometric and biochemical data.
- Logistic regression, restricted cubic spline (RCS), and ROC curve analyses to assess associations and predictive values.
Main Results
- VAI, CMI, and LAP were significantly higher in PCa patients compared to controls.
- Positive associations were found between VAI, CMI, LAP, and PCa risk, with VAI and CMI showing robust associations.
- Higher quartiles of VAI, CMI, and LAP correlated with increased PCa risk (e.g., OR for Q4 VAI: 9.07).
- RCS analysis revealed nonlinear associations for VAI and CMI, and linear for LAP.
- ROC analysis indicated moderate predictive values (AUCs: VAI=0.721, CMI=0.711, LAP=0.593).
Conclusions
- Visceral obesity indicators, specifically VAI and CMI, are closely associated with prostate cancer.
- VAI and CMI demonstrate good predictive value and robustness for assessing PCa risk.
- These indices can serve as potential biomarkers for prostate cancer risk assessment.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:24
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
01:29
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

